483
Immunity Bio, IncFDA 483 - Immunity Bio, Inc - February 10, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Immunity Bio, Inc. in Culver City, CA, received a Form 483 observation regarding deficiencies in clinical trial oversight. The firm failed to ensure proper monitoring of study QUILT-3.032, specifically concerning missing monitoring visit reports and undocumented site monitoring visits for several sites. This indicates issues with the management and documentation of clinical trial activities.
Open in Dashboard
ID · a00ed161-4217-432f-be55-111365031b36